Pardo-Lorente Natalia, Sdelci Sara
Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain.
NPJ Metab Health Dis. 2024 Mar 15;2(1):3. doi: 10.1038/s44324-024-00005-6.
Methylenetetrahydrofolate dehydrogenase 2 (MTHFD2) is a mitochondrial enzyme of the folate-mediated one-carbon metabolism pathway. MTHFD2 has become a highly attractive therapeutic target due to its consistent upregulation in cancer tissues and its major contribution to tumor progression, although it also performs vital functions in proliferating healthy cells. Here, we review the diversity of canonical and non-canonical functions of this key metabolic enzyme under physiological conditions and in carcinogenesis. We provide an overview of its therapeutic potential and describe its regulatory mechanisms. In addition, we discuss the recently described non-canonical functions of MTHFD2 and the mechanistic basis of its oncogenic function. Finally, we speculate on novel therapeutic approaches that take into account subcellular compartmentalization and outline new research directions that would contribute to a better understanding of the fundamental roles of this metabolic enzyme in health and disease.
亚甲基四氢叶酸脱氢酶2(MTHFD2)是叶酸介导的一碳代谢途径中的一种线粒体酶。尽管MTHFD2在增殖的健康细胞中也发挥着重要作用,但由于其在癌组织中持续上调且对肿瘤进展有主要贡献,它已成为一个极具吸引力的治疗靶点。在此,我们综述了这种关键代谢酶在生理条件和致癌过程中经典和非经典功能的多样性。我们概述了其治疗潜力并描述了其调控机制。此外,我们讨论了最近描述的MTHFD2的非经典功能及其致癌功能的机制基础。最后,我们推测了考虑亚细胞区室化的新型治疗方法,并概述了有助于更好理解这种代谢酶在健康和疾病中基本作用的新研究方向。